Moathalbliwi
@moathalbliwi
PGY-3 Internal Medicine Resident | Cleveland Clinic – Fairview Hospital | Aspiring Hematologist-Oncologist | Passionate about cancer care, research, education.
Just submitted my #HematologyOncologyfellowship application! Grateful to my mentors, co-residents, and the incredible leadership at my program for their support. Excited for what lies ahead! AAMC ID: 15136517 Moath Albliwi #HemeOnc #Match2026 #FutureOncologist @FairviewIMRes

Outstanding candidate with a strong track record. Highly recommended! @moathalbliwi
Just submitted my #HematologyOncologyfellowship application! Grateful to my mentors, co-residents, and the incredible leadership at my program for their support. Excited for what lies ahead! AAMC ID: 15136517 Moath Albliwi #HemeOnc #Match2026 #FutureOncologist
Honored to see our #ASCO25 abstract featured by @Healio. These findings challenge long-held assumptions and open new doors in understanding the “obesity paradox” in immunotherapy outcomes. Grateful for the opportunity to contribute. @moaathmustafaal #Immunotherapy #BMI
⚖️#ASCO25 data confirms patients with higher #BMI had IMPROVED 1-year survival ➕ LOWER risk of ICU/hospital admission and serious complications 💡Next step? “Determine why people with higher BMI have better outcomes.” -Dr. Moath Albliwi @ClevelandClinic healio.com/news/hematolog…
🚨 Just Submitted my #GIFellowship application! 💩 From Egypt to Houston to Cleveland, thankful for the journey. Grateful for my mentors. You’re my heros. Dedicated to advancing equitable care for liver patients. 📌AAMC ID: 13695481 🩺 Excited for what’s ahead! 💡 #ERAS2025
From #ENDO2025: #Osteoporosis treatment following #FragilityFracture was associated with significantly reduced #hospitalization and mortality risks among patients aged 80 years and older. @TheEndoSociety @moathalbliwi @DrAsfie @Aravinth01 endocrinologyadvisor.com/reports/osteop…
🥳 Excited to share our latest publication in the American Journal of Hematology, led by my outstanding mentee @johnhanna0! 🧬 We are the first to propose formal criteria for cytogenetic response in AML. 📢 Calling on my fellow leukemia specialists: we invite you to validate…
Honored to have 4 abstracts accepted at #ACG2025 — 2 oral, 2 posters! As a resident passionate about HemOnc, I’ve found that collaborating across specialities (GI, Endo, Cards, Primary Care) brings the most impactful ideas. I am grateful for a stellar team! 🙌 @FairviewIMRes

Excited to share our new publication in AJH: “Impact of Cytogenetic Response to Therapy on Long-Term Survival in AML” Grateful to work with an amazing Cleveland Clinic team under the mentorship of Dr. Moaath Mustafa Ali. 🔗 doi.org/10.1002/ajh.70… #AML #HemeOnc #Leukemia #CCFC
This made my day. I am grateful for the kind words, the incredible team I work with, and the chance to support patients & families when they need it most. 🫶👨⚕️ #MedTwitter #IMResidency #patientcare #Oncology

⭐️ Excited to share my new piece in Blood Cancers Today: “Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: From Discovery to the Edge of Cure | Blood Cancers Today” bloodcancerstoday.com/post/philadelp…
Every time I hear a clinical trial name in heme/onc, I get nervous to look it up; expecting complexity. But most are actually straightforward. If a trial feels too complex, it probably loses sight of the question it aims to answer. #HemOnc #ClincialTrials #Oncology #MedTwitter
Just published: Our new case series in Case Reports in Oncological Medicine highlights diagnostic and therapeutic challenges of cardiac metastases—rare, but clinically significant entity. #CardioOncology #MedTwitter #Oncology #Cardiology 📄 doi.org/10.1155/crom/7…
🚨🚨 In the FIRST of its kind study, we laid down the basis how to use immune therapy to prevent #cancer. 👉 “Can immune therapy prevent pre-clinical cancer from progression? The impact of immune therapy on secondary cancer incidence.” Please check out our abstract in…
First author on new paper: Diagnostic & Therapeutic Challenges of Cardiac Metastases in Advanced Cancers published in Case Reports in Oncological Medicine. Early detection & imaging are key despite poor prognosis. Read more: doi.org/10.1155/crom/7… #CardioOncology #CancerResearch
Evaluation and Treatment of Iron Deficiency for the Practicing Oncologist | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… @JCOOP_ASCO @ASCO @JCO_ASCO @OncoAlert
Presented our abstract at #ASCO25 on BMI & immunotherapy in solid tumors—featured by @Healio & @VuMedi video below& @VJoncology 📊 Data supports the “obesity paradox” with better outcomes in higher BMI patients.@ClevelandClinic 🔗 healio.com/news/hematolog… #Oncology #Immunotherapy
Excited to share that my mentee @moathalbliwi from @CleClinicMD will be presenting at #ASCO2025 on how obesity affects immune therapy outcomes — tackling the intriguing obesity paradox. Big work ahead!
Honored to present my abstract at #ASH2024 alongside my mentor, @Ali_emia Grateful for his guidance and the opportunity to connect with incredible minds in the field of Hematology-Oncology. Here's to learning, growth, and making lifelong friendship #ASHAnnualMeeting
